Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA 644a (MIR644A) is a short, endogenous non-coding RNA that regulates gene expression by binding to complementary sequences in the 3’-untranslated region (3’-UTR) of target mRNAs, leading to mRNA degradation or translational inhibition[2]. MIR644A is transcribed by RNA polymerase II as part of longer primary transcripts and processed sequentially by Drosha and Dicer enzymes to produce a mature miRNA, which is integrated into the RNA-induced silencing complex (RISC) to exert its function[2]. In hepatocellular carcinoma cells, miR-644a is downregulated compared to normal tissue, and restoration of its expression induces apoptosis by directly inhibiting Heat Shock Factor 1 (HSF1), a key transcription factor involved in stress response and cell survival[1]. Overexpression of miR-644a increases levels of pro-apoptotic BH3-only proteins (such as BID, BAD, BIM, SMAC, Apaf-1), further supporting its role in promoting cell death. miR-644a has also been described as a tumor suppressor in other cancers, including breast and esophageal cancer, where it modulates proliferation and drug resistance[1]. Overall, miR-644a is considered a potential prognostic biomarker and an experimental therapeutic target in oncology, though no approved drugs target it directly at present[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MicroRNA 644a (MIR644A).